ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 189 filers reported holding ANI PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,055,415 | +7.9% | 18,178 | 0.0% | 0.68% | +19.3% |
| Q2 2023 | $978,522 | +35.5% | 18,178 | 0.0% | 0.57% | +28.1% |
| Q1 2023 | $722,030 | -1.3% | 18,178 | 0.0% | 0.44% | -5.7% |
| Q4 2022 | $731,301 | +25.2% | 18,178 | 0.0% | 0.47% | +12.4% |
| Q3 2022 | $584,000 | +8.3% | 18,178 | 0.0% | 0.42% | +18.6% |
| Q2 2022 | $539,000 | +5.5% | 18,178 | 0.0% | 0.35% | +30.6% |
| Q1 2022 | $511,000 | -74.6% | 18,178 | -58.3% | 0.27% | -72.6% |
| Q4 2021 | $2,010,000 | +236.7% | 43,611 | +139.9% | 0.99% | +227.8% |
| Q3 2021 | $597,000 | -6.3% | 18,178 | 0.0% | 0.30% | -7.1% |
| Q2 2021 | $637,000 | -51.5% | 18,178 | -50.0% | 0.32% | -14.0% |
| Q1 2021 | $1,314,000 | +92.4% | 36,356 | +54.5% | 0.38% | -4.1% |
| Q4 2020 | $683,000 | -3.1% | 23,533 | -5.9% | 0.39% | -25.4% |
| Q3 2020 | $705,000 | -13.1% | 25,003 | -0.3% | 0.53% | -23.9% |
| Q2 2020 | $811,000 | -20.6% | 25,070 | 0.0% | 0.69% | -43.2% |
| Q1 2020 | $1,021,000 | -34.0% | 25,070 | -0.1% | 1.22% | -10.7% |
| Q4 2019 | $1,547,000 | -15.7% | 25,093 | -0.3% | 1.37% | -23.5% |
| Q3 2019 | $1,835,000 | -11.4% | 25,181 | 0.0% | 1.79% | -7.6% |
| Q2 2019 | $2,070,000 | +14.2% | 25,181 | -2.0% | 1.94% | +26.2% |
| Q1 2019 | $1,812,000 | +40.0% | 25,691 | -10.6% | 1.53% | +32.2% |
| Q4 2018 | $1,294,000 | -22.7% | 28,741 | -2.9% | 1.16% | +6.5% |
| Q3 2018 | $1,673,000 | -20.8% | 29,586 | -6.5% | 1.09% | -27.8% |
| Q2 2018 | $2,113,000 | -0.1% | 31,636 | -12.9% | 1.51% | -7.1% |
| Q1 2018 | $2,115,000 | -7.2% | 36,321 | +2.7% | 1.62% | -8.6% |
| Q4 2017 | $2,278,000 | +0.1% | 35,349 | -18.5% | 1.78% | -11.7% |
| Q3 2017 | $2,276,000 | +12.1% | 43,367 | -0.0% | 2.01% | +12.4% |
| Q2 2017 | $2,030,000 | -6.0% | 43,381 | -0.5% | 1.79% | +6.6% |
| Q1 2017 | $2,159,000 | -16.4% | 43,608 | +2.4% | 1.68% | -15.7% |
| Q4 2016 | $2,582,000 | +12.8% | 42,598 | +23.5% | 1.99% | +6.5% |
| Q3 2016 | $2,289,000 | – | 34,500 | – | 1.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |